Molecular biological studies on the formation of atherogenic small dense low density lipoprotein (sLDL)
致动脉粥样硬化小致密低密度脂蛋白(sLDL)形成的分子生物学研究
基本信息
- 批准号:06671066
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have systematically investigated the mechanism of formation of small dense low density lipoprotein (sLDL) in the circulation which is known to be one of risk factors for atherosclerosis. As sLDL is high frequently found on patients with type IV hypertriglyceridemia, we first attempted to clarify an underlying etiology of type IV hypertriglyceridemia by monitoring LPL immunoreactive mass in postheparin plasma of 32 non-diabetic patients with type IV hypertriglyceridemia using our sandwich-EIA technique for the first screenig, followed by a second screening for LPL gene aberrations using PCR-SSCP and direct sequencing methods. By this approach, we found that heterozygous LPL deficiency was an underlying genetic disorder of type IV hypertriglyceridemia, and that subjects with heterozygous LPL deficiency are prone to manifest type IV hypertriglyceridemia when they acquire triglyceride (TG) synthesis stimulating factors like high alcohol intake.In order to understand the mechanism of the formation of sLDL under hypertriglyceridemia, lipoproteins isolated from 30 subjects with type IV hypertriglyceridemia and 30 normal subjects were compared. The ratio of TG over cholesterol ester (CE) in HDL (HDL-TG/CE) was correlated with serum TG concentration derived from TG-rich lipoproteins such as VLDL.Factors correlating with LDL size variation were further searched, and the variation of LDL size was reversely correlated with HDL-TG/CE ratio and hepatic triglyceride lipase (HTGL) immunoreactive mass in PHP.These statistical data were confirmed by in vitro experiments in which lipid composition of HDL is changed into TG-rich and CE-poor particle via lipid transfer protein action by interacting with high amount of VLDL corresponding to type IV hypertriglyceridemia, and LDL is converted into TG-rich and CE-poor particle by interacting with TG-rich/CE-poor HDL,and in the final step TG hydrolysis of LDL by HTGL action results in the formation of sLDL.
我们系统地研究了小密度低密度脂蛋白(sLDL)在血液循环中的形成机制,它被认为是动脉粥样硬化的危险因素之一。由于sLDL在IV型高甘油三酯血症患者中非常常见,我们首先使用三明治- eia技术进行第一次筛查,通过监测32例非糖尿病型高甘油三酯血症患者的肝素后血浆中的LPL免疫反应性块,然后使用PCR-SSCP和直接测序方法进行第二次筛查LPL基因异常,试图阐明IV型高甘油三酯血症的潜在病因。通过这种方法,我们发现杂合性LPL缺乏症是IV型高甘油三酯血症的潜在遗传疾病,并且杂合性LPL缺乏症的受试者在获得甘油三酯(TG)合成刺激因素(如高酒精摄入)时容易出现IV型高甘油三酯血症。为了了解高甘油三酯血症下sLDL形成的机制,我们比较了30例IV型高甘油三酯血症患者和30例正常人的脂蛋白。HDL中TG/胆固醇酯(CE)的比值(HDL-TG/CE)与血清中由富含TG的脂蛋白(如VLDL)产生的TG浓度相关。进一步寻找LDL大小变化的相关因素,发现LDL大小变化与PHP中HDL-TG/CE比值和肝甘油三酯脂肪酶(HTGL)免疫反应质量呈负相关。这些统计数据通过体外实验得到证实,HDL的脂质组成通过脂质转移蛋白作用与IV型高甘油三酯血症对应的大量VLDL相互作用,转化为富TG和贫ce的颗粒,LDL通过与富TG /贫ce的HDL相互作用转化为富TG和贫ce的颗粒,最后通过HTGL作用TG水解LDL形成sLDL。
项目成果
期刊论文数量(92)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A.Yamamoto: "Multiple Risk Factors in Cardiovascular Disease" Churchill Livingstone,Japan, 277 (1994)
A.Yamamoto:“心血管疾病的多种危险因素”Churchill Livingstone,日本,277 (1994)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y.Ikeda, A.Takagi, A.Yamamoto: "Elucidation of an underlying etiology of primary type IV hyperlipoproteinemia : heterozygous lipoprotein lipase deficiency as a casual genetic disorder." In : Current Advances in Triglycerides and Atherosclerosis (ED.by A.Y
Y.Ikeda、A.Takagi、A.Yamamoto:“阐明原发性 IV 型高脂蛋白血症的潜在病因:杂合性脂蛋白脂肪酶缺乏症是一种偶然的遗传性疾病。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
A.Yamamoto, T.Yamamura, Y.Miyake, Y.Ikeda, A.Takagi, M.Harada-Shiba.: "Hereditary traits and individual differences in the expression of hyper-or dys-lipoproteinemia." In : Multiple Risk Factors in Cardiovascular Disease (Ed.by A.Yamamoto), Churchill Livi
A.Yamamoto、T.Yamamura、Y.Miyake、Y.Ikeda、A.Takagi、M.Harada-Shiba.:“高脂蛋白血症或异常脂蛋白血症表达的遗传性状和个体差异。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
高木敦子: "リポ蛋白リパーゼ(LDL)." 日本臨床. 53. 639-643 (1995)
Atsuko Takagi:“脂蛋白脂肪酶 (LDL)”,日本临床 53. 639-643 (1995)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
池田康行: "高トリグリセライド血症をどう考えるか(2)リポ蛋白リパーゼ" Progress in Medicine. 15. 2343-2357 (1995)
池田康之:“如何看待高甘油三酯血症(2)脂蛋白脂肪酶”医学进展15。2343-2357(1995)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IKEDA Yasuyuki其他文献
IKEDA Yasuyuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IKEDA Yasuyuki', 18)}}的其他基金
動脈硬化性疾患の発症に直結する新規バイオマーカーの発見と早期診断・治療法の開発
发现与动脉硬化疾病发病直接相关的新生物标志物以及开发早期诊断和治疗方法
- 批准号:
20300232 - 财政年份:2008
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of genetic diagnostics, preventive and development of treatment for atherogenic hypertriglyceridemia
动脉粥样硬化性高甘油三酯血症的基因诊断、预防和治疗方法的建立
- 批准号:
16300228 - 财政年份:2004
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of an early diagnostic system for the detection of heart disease-related gene mutations with a novel electrochemical array chip
新型电化学阵列芯片建立心脏病相关基因突变早期诊断系统
- 批准号:
14570376 - 财政年份:2002
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development and application of DNA tip for the diagnosis of atherogenic hypertriglyceridemia
DNA探针诊断动脉粥样硬化性高甘油三酯血症的开发及应用
- 批准号:
12670384 - 财政年份:2000
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular Biological Study on Regulation and Expression of Physiological Function of Human Lipoprotein Lipase
人脂蛋白脂肪酶生理功能调控与表达的分子生物学研究
- 批准号:
01580206 - 财政年份:1989
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Lipase Maturation Factor 1 in Hypertriglyceridemia
高甘油三酯血症中的脂肪酶成熟因子 1
- 批准号:
10203561 - 财政年份:2021
- 资助金额:
$ 1.34万 - 项目类别:
Metabolic heterogeneity underlying hypertriglyceridemia in insulin resistance
胰岛素抵抗导致高甘油三酯血症的代谢异质性
- 批准号:
10359154 - 财政年份:2020
- 资助金额:
$ 1.34万 - 项目类别:
Metabolic heterogeneity underlying hypertriglyceridemia in insulin resistance
胰岛素抵抗导致高甘油三酯血症的代谢异质性
- 批准号:
10571887 - 财政年份:2020
- 资助金额:
$ 1.34万 - 项目类别:
Pathophysiology and therapeutic strategy of autoimmune hypertriglyceridemia.
自身免疫性高甘油三酯血症的病理生理学和治疗策略。
- 批准号:
20KK0190 - 财政年份:2020
- 资助金额:
$ 1.34万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
Molecular dissection and therapeutic development of hypertriglyceridemia-induced acute pancreatitis
高甘油三酯血症诱发急性胰腺炎的分子解析及治疗进展
- 批准号:
20K21595 - 财政年份:2020
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Molecular mechanisms and therapeutic targets of severe hypertriglyceridemia
重度高甘油三酯血症的分子机制和治疗靶点
- 批准号:
18K08467 - 财政年份:2018
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetics of hypertriglyceridemia: an assortment of polygenic effects
高甘油三酯血症的遗传学:多种多基因效应
- 批准号:
382987 - 财政年份:2018
- 资助金额:
$ 1.34万 - 项目类别:
Molecular mechanisms and therapeutic targets of atherogenic hypertriglyceridemia
致动脉粥样硬化性高甘油三酯血症的分子机制和治疗靶点
- 批准号:
17K09858 - 财政年份:2017
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetic analysis of lipid related genes in patients with hypertriglyceridemia and low HDL cholesterolemia
高甘油三酯血症和低HDL胆固醇血症患者脂质相关基因的遗传分析
- 批准号:
16K08955 - 财政年份:2016
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the action domain of polyunsaturated fatty acids to develop new drug for hypertriglyceridemia
阐明多不饱和脂肪酸的作用域,开发治疗高甘油三酯血症的新药
- 批准号:
16K13040 - 财政年份:2016
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research